Please login to the form below

Not currently logged in

VMLY&Rx taps Nichole Davies for global chief strategy officer role

Davies will head up a new global strategic practice at VMLY&Rx

Specialist pharma agency network VMLY&Rx has announced the appointment of Nichole Davies (pictured above) as global chief strategy officer.

VMLY&Rx is solely dedicated to prescription medicines pharmaceutical companies that are researching, developing and commercialising breakthrough therapies.

Davies will head up a new global strategic practice at VMLY&Rx, aiming to deliver and enable connected health strategies for clients.

Prior to joining VMLY&Rx, Davies worked as global chief strategy officer at WPP Health Practice, and previously served as chief strategy officer for Wunderman Thompson Health.

Her experience spans a number of areas, including oncology and immunology, rare disease, respiratory, women’s health, diabetes, nutrition and hospitals.

“As anyone who works in the health will testify,  there is less time and more to do. Today’s health environment is complex, fast paced and demanding.  We need to find new ways of connecting with busy healthcare professionals,” said Claire Gillis, global chief executive officer of VMLY&Rx.

“The strain the pandemic has placed on our health systems around the world has only added to the challenge. Having a strong change maker like Nichole to help us lead this transformation gives our teams and our clients the opportunity to do something that unities us all: to create better health experiences,” she added.

Article by
Lucy Parsons

31st March 2021

From: Marketing


Subscribe to our email news alerts

Featured jobs


Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...